25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Corbion NV ADR
Buy, Hold or Sell?

Let's analyze Corbion together

I guess you are interested in Corbion NV ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Corbion NV ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Corbion NV ADR

I send you an email if I find something interesting about Corbion NV ADR.

1. Quick Overview

1.1. Quick analysis of Corbion (30 sec.)










1.2. What can you expect buying and holding a share of Corbion? (30 sec.)

How much money do you get?

How much money do you get?
$2.46
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$10.66
Expected worth in 1 year
$11.22
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
$3.02
Return On Investment
11.6%

For what price can you sell your share?

Current Price per Share
$26.00
Expected price per share
$23.99 - $32.60
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Corbion (5 min.)




Live pricePrice per Share (EOD)
$26.00
Intrinsic Value Per Share
$-16.43 - $5.42
Total Value Per Share
$-5.77 - $16.08

2.2. Growth of Corbion (5 min.)




Is Corbion growing?

Current yearPrevious yearGrowGrow %
How rich?$636.2m$625.7m$10.5m1.7%

How much money is Corbion making?

Current yearPrevious yearGrowGrow %
Making money$80.7m$99.6m-$18.9m-23.5%
Net Profit Margin5.0%6.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Corbion (5 min.)




2.4. Comparing to competitors in the Specialty Chemicals industry (5 min.)




  Industry Rankings (Specialty Chemicals)  


Richest
#133 / 555

Most Revenue
#51 / 555

Most Profit
#49 / 555

Most Efficient
#225 / 555
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Corbion?

Welcome investor! Corbion's management wants to use your money to grow the business. In return you get a share of Corbion.

First you should know what it really means to hold a share of Corbion. And how you can make/lose money.

Speculation

The Price per Share of Corbion is $26.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Corbion.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Corbion, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $10.66. Based on the TTM, the Book Value Change Per Share is $0.14 per quarter. Based on the YOY, the Book Value Change Per Share is $1.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.61 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Corbion.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.355.2%1.355.2%1.686.4%1.274.9%1.184.5%
Usd Book Value Change Per Share0.140.5%0.140.5%1.194.6%0.381.4%0.351.4%
Usd Dividend Per Share0.612.4%0.612.4%0.612.4%0.612.4%0.702.7%
Usd Total Gains Per Share0.752.9%0.752.9%1.806.9%0.993.8%1.054.0%
Usd Price Per Share21.41-21.41-33.98-38.03-26.29-
Price to Earnings Ratio15.83-15.83-20.28-35.05-17.47-
Price-to-Total Gains Ratio28.36-28.36-18.86-55.30-43.60-
Price to Book Ratio2.01-2.01-3.23-4.06-2.92-
Price-to-Total Gains Ratio28.36-28.36-18.86-55.30-43.60-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share26
Number of shares38
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.610.61
Usd Book Value Change Per Share0.140.38
Usd Total Gains Per Share0.750.99
Gains per Quarter (38 shares)28.6837.67
Gains per Year (38 shares)114.73150.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
193211059357141
218743220187115292
328064335280172443
437386450374229594
5467107565467286745
6560128680560344896
76531507956544011047
87471719107474581198
984019210258405161349
1093421411409345731500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%18.04.00.081.8%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%7.03.00.070.0%14.08.00.063.6%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.03.00.086.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Corbion NV ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1410.1410%1.188-88%0.377-63%0.351-60%
Book Value Per Share--10.65710.6570%10.516+1%9.616+11%8.984+19%
Current Ratio--0.9850.9850%1.104-11%1.276-23%1.553-37%
Debt To Asset Ratio--0.6260.6260%0.633-1%0.576+9%0.491+27%
Debt To Equity Ratio--1.6721.6720%1.726-3%1.392+20%1.040+61%
Dividend Per Share--0.6140.6140%0.6140%0.6140%0.698-12%
Eps--1.3531.3530%1.676-19%1.266+7%1.182+14%
Free Cash Flow Per Share--0.3840.3840%-3.664+1054%-0.910+337%-0.029+108%
Free Cash Flow To Equity Per Share--0.2860.2860%-0.426+249%-0.095+133%-0.047+116%
Gross Profit Margin---0.023-0.0230%0.099-124%-0.255+994%0.401-106%
Intrinsic Value_10Y_max--5.420--------
Intrinsic Value_10Y_min---16.426--------
Intrinsic Value_1Y_max--0.094--------
Intrinsic Value_1Y_min---1.838--------
Intrinsic Value_3Y_max--0.625--------
Intrinsic Value_3Y_min---5.390--------
Intrinsic Value_5Y_max--1.569--------
Intrinsic Value_5Y_min---8.767--------
Market Cap1510561000.000+15%1278057600.0001278057600.0000%2021869500.000-37%2262008120.000-43%1568775170.000-19%
Net Profit Margin--0.0500.0500%0.062-18%0.057-12%0.062-18%
Operating Margin--0.0890.0890%0.088+1%0.081+9%0.088+0%
Operating Ratio--0.9110.9110%0.929-2%0.926-2%0.9120%
Pb Ratio2.440+18%2.0092.0090%3.231-38%4.062-51%2.919-31%
Pe Ratio19.222+18%15.82715.8270%20.281-22%35.049-55%17.469-9%
Price Per Share26.000+18%21.40821.4080%33.981-37%38.029-44%26.287-19%
Price To Free Cash Flow Ratio67.695+18%55.73955.7390%-9.275+117%44.858+24%-66.475+219%
Price To Total Gains Ratio34.446+18%28.36228.3620%18.857+50%55.301-49%43.599-35%
Quick Ratio--0.5390.5390%0.436+23%0.543-1%0.749-28%
Return On Assets--0.0480.0480%0.058-19%0.054-13%0.067-29%
Return On Equity--0.1270.1270%0.159-20%0.131-3%0.133-5%
Total Gains Per Share--0.7550.7550%1.802-58%0.991-24%1.049-28%
Usd Book Value--636200000.000636200000.0000%625700000.000+2%572220000.000+11%536560000.000+19%
Usd Book Value Change Per Share--0.1410.1410%1.188-88%0.377-63%0.351-60%
Usd Book Value Per Share--10.65710.6570%10.516+1%9.616+11%8.984+19%
Usd Dividend Per Share--0.6140.6140%0.6140%0.6140%0.698-12%
Usd Eps--1.3531.3530%1.676-19%1.266+7%1.182+14%
Usd Free Cash Flow--22929390.00022929390.0000%-217995360.000+1051%-54077914.000+336%-1794474.000+108%
Usd Free Cash Flow Per Share--0.3840.3840%-3.664+1054%-0.910+337%-0.029+108%
Usd Free Cash Flow To Equity Per Share--0.2860.2860%-0.426+249%-0.095+133%-0.047+116%
Usd Market Cap1510561000.000+15%1278057600.0001278057600.0000%2021869500.000-37%2262008120.000-43%1568775170.000-19%
Usd Price Per Share26.000+18%21.40821.4080%33.981-37%38.029-44%26.287-19%
Usd Profit--80751330.00080751330.0000%99693000.000-19%75345754.000+7%71391265.000+13%
Usd Revenue--1599297260.0001599297260.0000%1614915830.000-1%1314928516.000+22%1143589480.000+40%
Usd Total Gains Per Share--0.7550.7550%1.802-58%0.991-24%1.049-28%
 EOD+4 -4MRQTTM+0 -0YOY+17 -195Y+18 -1810Y+17 -19

3.3 Fundamental Score

Let's check the fundamental score of Corbion NV ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.222
Price to Book Ratio (EOD)Between0-12.440
Net Profit Margin (MRQ)Greater than00.050
Operating Margin (MRQ)Greater than00.089
Quick Ratio (MRQ)Greater than10.539
Current Ratio (MRQ)Greater than10.985
Debt to Asset Ratio (MRQ)Less than10.626
Debt to Equity Ratio (MRQ)Less than11.672
Return on Equity (MRQ)Greater than0.150.127
Return on Assets (MRQ)Greater than0.050.048
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Corbion NV ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5083.829
Ma 20Greater thanMa 5024.816
Ma 50Greater thanMa 10022.833
Ma 100Greater thanMa 20022.206
OpenGreater thanClose26.000
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Corbion NV ADR

Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was incorporated in 1919 and is headquartered in Amsterdam, the Netherlands.

Fundamental data was last updated by Penke on 2024-08-31 02:06:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Corbion earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Corbion to the Specialty Chemicals industry mean.
  • A Net Profit Margin of 5.0% means that $0.05 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Corbion NV ADR:

  • The MRQ is 5.0%. The company is making a profit. +1
  • The TTM is 5.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.0%TTM5.0%0.0%
TTM5.0%YOY6.2%-1.1%
TTM5.0%5Y5.7%-0.7%
5Y5.7%10Y6.2%-0.5%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0%4.6%+0.4%
TTM5.0%3.7%+1.3%
YOY6.2%4.6%+1.6%
5Y5.7%5.8%-0.1%
10Y6.2%6.0%+0.2%
4.3.1.2. Return on Assets

Shows how efficient Corbion is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Corbion to the Specialty Chemicals industry mean.
  • 4.8% Return on Assets means that Corbion generated $0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Corbion NV ADR:

  • The MRQ is 4.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.8%TTM4.8%0.0%
TTM4.8%YOY5.8%-1.1%
TTM4.8%5Y5.4%-0.7%
5Y5.4%10Y6.7%-1.2%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8%1.1%+3.7%
TTM4.8%1.0%+3.8%
YOY5.8%1.2%+4.6%
5Y5.4%1.4%+4.0%
10Y6.7%1.6%+5.1%
4.3.1.3. Return on Equity

Shows how efficient Corbion is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Corbion to the Specialty Chemicals industry mean.
  • 12.7% Return on Equity means Corbion generated $0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Corbion NV ADR:

  • The MRQ is 12.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.7%TTM12.7%0.0%
TTM12.7%YOY15.9%-3.2%
TTM12.7%5Y13.1%-0.4%
5Y13.1%10Y13.3%-0.3%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ12.7%2.0%+10.7%
TTM12.7%1.8%+10.9%
YOY15.9%2.1%+13.8%
5Y13.1%2.5%+10.6%
10Y13.3%2.7%+10.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Corbion NV ADR.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Corbion is operating .

  • Measures how much profit Corbion makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Corbion to the Specialty Chemicals industry mean.
  • An Operating Margin of 8.9% means the company generated $0.09  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Corbion NV ADR:

  • The MRQ is 8.9%. The company is operating less efficient.
  • The TTM is 8.9%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ8.9%TTM8.9%0.0%
TTM8.9%YOY8.8%+0.1%
TTM8.9%5Y8.1%+0.7%
5Y8.1%10Y8.8%-0.7%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9%8.7%+0.2%
TTM8.9%3.8%+5.1%
YOY8.8%6.1%+2.7%
5Y8.1%7.2%+0.9%
10Y8.8%7.3%+1.5%
4.3.2.2. Operating Ratio

Measures how efficient Corbion is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • An Operation Ratio of 0.91 means that the operating costs are $0.91 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Corbion NV ADR:

  • The MRQ is 0.911. The company is less efficient in keeping operating costs low.
  • The TTM is 0.911. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.911TTM0.9110.000
TTM0.911YOY0.929-0.018
TTM0.9115Y0.926-0.014
5Y0.92610Y0.912+0.014
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9111.523-0.612
TTM0.9111.475-0.564
YOY0.9291.441-0.512
5Y0.9261.425-0.499
10Y0.9121.201-0.289
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Corbion NV ADR.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Corbion is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Current Ratio of 0.99 means the company has $0.99 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Corbion NV ADR:

  • The MRQ is 0.985. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.985. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.985TTM0.9850.000
TTM0.985YOY1.104-0.119
TTM0.9855Y1.276-0.290
5Y1.27610Y1.553-0.277
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9851.837-0.852
TTM0.9851.865-0.880
YOY1.1041.950-0.846
5Y1.2761.979-0.703
10Y1.5531.837-0.284
4.4.3.2. Quick Ratio

Measures if Corbion is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Corbion to the Specialty Chemicals industry mean.
  • A Quick Ratio of 0.54 means the company can pay off $0.54 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Corbion NV ADR:

  • The MRQ is 0.539. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.539. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.539TTM0.5390.000
TTM0.539YOY0.436+0.102
TTM0.5395Y0.543-0.004
5Y0.54310Y0.749-0.207
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5390.841-0.302
TTM0.5390.880-0.341
YOY0.4361.015-0.579
5Y0.5431.105-0.562
10Y0.7491.131-0.382
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Corbion NV ADR.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Corbion assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Corbion to Specialty Chemicals industry mean.
  • A Debt to Asset Ratio of 0.63 means that Corbion assets are financed with 62.6% credit (debt) and the remaining percentage (100% - 62.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Corbion NV ADR:

  • The MRQ is 0.626. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.626. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.626TTM0.6260.000
TTM0.626YOY0.633-0.007
TTM0.6265Y0.576+0.050
5Y0.57610Y0.491+0.085
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6260.428+0.198
TTM0.6260.427+0.199
YOY0.6330.423+0.210
5Y0.5760.426+0.150
10Y0.4910.430+0.061
4.5.4.2. Debt to Equity Ratio

Measures if Corbion is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Corbion to the Specialty Chemicals industry mean.
  • A Debt to Equity ratio of 167.2% means that company has $1.67 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Corbion NV ADR:

  • The MRQ is 1.672. The company is just able to pay all its debts with equity.
  • The TTM is 1.672. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.672TTM1.6720.000
TTM1.672YOY1.726-0.054
TTM1.6725Y1.392+0.279
5Y1.39210Y1.040+0.352
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6720.770+0.902
TTM1.6720.765+0.907
YOY1.7260.732+0.994
5Y1.3920.808+0.584
10Y1.0400.833+0.207
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Corbion generates.

  • Above 15 is considered overpriced but always compare Corbion to the Specialty Chemicals industry mean.
  • A PE ratio of 15.83 means the investor is paying $15.83 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Corbion NV ADR:

  • The EOD is 19.222. Based on the earnings, the company is fair priced.
  • The MRQ is 15.827. Based on the earnings, the company is fair priced.
  • The TTM is 15.827. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD19.222MRQ15.827+3.395
MRQ15.827TTM15.8270.000
TTM15.827YOY20.281-4.454
TTM15.8275Y35.049-19.222
5Y35.04910Y17.469+17.581
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD19.22216.066+3.156
MRQ15.82715.821+0.006
TTM15.82715.800+0.027
YOY20.28115.622+4.659
5Y35.04919.322+15.727
10Y17.46923.925-6.456
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Corbion NV ADR:

  • The EOD is 67.695. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 55.739. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 55.739. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD67.695MRQ55.739+11.956
MRQ55.739TTM55.7390.000
TTM55.739YOY-9.275+65.014
TTM55.7395Y44.858+10.881
5Y44.85810Y-66.475+111.333
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD67.6953.205+64.490
MRQ55.7392.938+52.801
TTM55.7392.833+52.906
YOY-9.2752.430-11.705
5Y44.8583.153+41.705
10Y-66.4752.682-69.157
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Corbion is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 2.01 means the investor is paying $2.01 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Corbion NV ADR:

  • The EOD is 2.440. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.009. Based on the equity, the company is underpriced. +1
  • The TTM is 2.009. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.440MRQ2.009+0.431
MRQ2.009TTM2.0090.000
TTM2.009YOY3.231-1.222
TTM2.0095Y4.062-2.053
5Y4.06210Y2.919+1.144
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD2.4401.698+0.742
MRQ2.0091.708+0.301
TTM2.0091.787+0.222
YOY3.2311.892+1.339
5Y4.0622.324+1.738
10Y2.9192.786+0.133
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Net Working Capital  24,800126,400151,20032,300183,500-121,90061,600-70,200-8,600



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,699,700
Total Liabilities1,063,500
Total Stockholder Equity636,200
 As reported
Total Liabilities 1,063,500
Total Stockholder Equity+ 636,200
Total Assets = 1,699,700

Assets

Total Assets1,699,700
Total Current Assets579,700
Long-term Assets1,120,000
Total Current Assets
Cash And Cash Equivalents 70,200
Net Receivables 246,600
Inventory 262,900
Total Current Assets  (as reported)579,700
Total Current Assets  (calculated)579,700
+/- 0
Long-term Assets
Property Plant Equipment 798,400
Goodwill 81,300
Intangible Assets 51,000
Long-term Assets Other 60,800
Long-term Assets  (as reported)1,120,000
Long-term Assets  (calculated)991,500
+/- 128,500

Liabilities & Shareholders' Equity

Total Current Liabilities588,300
Long-term Liabilities475,200
Total Stockholder Equity636,200
Total Current Liabilities
Short-term Debt 368,500
Short Long Term Debt 356,000
Accounts payable 104,300
Other Current Liabilities 113,000
Total Current Liabilities  (as reported)588,300
Total Current Liabilities  (calculated)941,800
+/- 353,500
Long-term Liabilities
Long term Debt 364,600
Capital Lease Obligations 64,900
Long-term Liabilities Other 12,800
Long-term Liabilities  (as reported)475,200
Long-term Liabilities  (calculated)442,300
+/- 32,900
Total Stockholder Equity
Common Stock14,800
Retained Earnings 540,600
Accumulated Other Comprehensive Income 25,600
Other Stockholders Equity 55,200
Total Stockholder Equity (as reported)636,200
Total Stockholder Equity (calculated)636,200
+/-0
Other
Capital Stock14,800
Cash and Short Term Investments 70,200
Common Stock Shares Outstanding 59,700
Current Deferred Revenue2,500
Liabilities and Stockholders Equity 1,699,700
Net Debt 715,300
Net Invested Capital 1,356,800
Net Working Capital -8,600
Property Plant and Equipment Gross 1,543,000
Short Long Term Debt Total 785,500



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
> Total Assets 
2,498,300
2,765,400
2,674,000
2,183,400
2,225,100
2,048,300
2,106,500
2,003,700
2,627,300
2,415,300
2,185,300
765,600
783,600
808,000
843,000
830,800
965,800
1,091,100
1,074,500
1,341,100
1,705,400
1,699,700
1,699,7001,705,4001,341,1001,074,5001,091,100965,800830,800843,000808,000783,600765,6002,185,3002,415,3002,627,3002,003,7002,106,5002,048,3002,225,1002,183,4002,674,0002,765,4002,498,300
   > Total Current Assets 
1,075,300
1,111,800
1,372,500
856,600
869,500
699,400
745,600
674,200
836,200
856,400
1,757,200
330,100
350,500
338,200
376,400
332,700
349,600
372,500
385,100
504,500
654,300
579,700
579,700654,300504,500385,100372,500349,600332,700376,400338,200350,500330,1001,757,200856,400836,200674,200745,600699,400869,500856,6001,372,5001,111,8001,075,300
       Cash And Cash Equivalents 
10,900
87,900
76,100
78,300
80,200
37,700
83,600
120,400
118,700
116,000
60,200
123,900
111,400
92,100
60,800
38,100
47,100
45,700
51,600
42,200
58,200
70,200
70,20058,20042,20051,60045,70047,10038,10060,80092,100111,400123,90060,200116,000118,700120,40083,60037,70080,20078,30076,10087,90010,900
       Net Receivables 
0
0
339,900
0
329,600
395,400
0
0
0
0
0
83,800
94,900
110,900
125,600
162,100
149,800
163,600
156,900
231,200
264,900
246,600
246,600264,900231,200156,900163,600149,800162,100125,600110,90094,90083,80000000395,400329,6000339,90000
       Inventory 
510,500
501,000
391,500
403,400
246,400
256,100
311,000
251,100
335,400
337,900
104,600
97,100
128,400
133,000
137,700
128,300
152,700
163,200
164,800
230,000
331,200
262,900
262,900331,200230,000164,800163,200152,700128,300137,700133,000128,40097,100104,600337,900335,400251,100311,000256,100246,400403,400391,500501,000510,500
       Other Current Assets 
553,900
522,900
565,000
374,900
213,300
10,200
351,000
302,700
382,100
402,500
1,592,400
25,300
15,800
2,200
52,300
4,200
149,800
39,400
11,800
1,100
54,400
45,700
45,70054,4001,10011,80039,400149,8004,20052,3002,20015,80025,3001,592,400402,500382,100302,700351,00010,200213,300374,900565,000522,900553,900
   > Long-term Assets 
1,423,000
1,653,600
1,301,500
1,326,800
1,355,600
1,348,900
1,360,900
1,329,500
1,791,100
1,558,900
428,100
435,500
433,100
469,800
466,600
498,100
616,200
718,600
689,400
836,600
1,051,100
1,120,000
1,120,0001,051,100836,600689,400718,600616,200498,100466,600469,800433,100435,500428,1001,558,9001,791,1001,329,5001,360,9001,348,9001,355,6001,326,8001,301,5001,653,6001,423,000
       Property Plant Equipment 
768,000
844,700
593,900
618,900
585,600
519,800
513,400
499,900
574,600
583,000
303,000
310,200
288,700
307,400
297,200
280,000
368,900
433,000
406,500
532,900
729,500
798,400
798,400729,500532,900406,500433,000368,900280,000297,200307,400288,700310,200303,000583,000574,600499,900513,400519,800585,600618,900593,900844,700768,000
       Goodwill 
0
0
627,900
646,300
674,500
693,900
0
0
0
0
53,700
51,900
58,200
64,200
66,200
58,800
61,300
80,400
70,100
77,700
83,500
81,300
81,30083,50077,70070,10080,40061,30058,80066,20064,20058,20051,90053,7000000693,900674,500646,300627,90000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
6,900
7,985
6,400
5,000
26,200
19,200
83,800
0
0
0
0
000083,80019,20026,2005,0006,4007,9856,90000000000000
       Intangible Assets 
599,500
739,400
0
2,600
27,800
77,700
773,700
765,900
1,146,800
912,400
39,700
45,600
64,700
74,400
72,000
71,500
77,900
92,500
95,600
80,200
80,100
51,000
51,00080,10080,20095,60092,50077,90071,50072,00074,40064,70045,60039,700912,4001,146,800765,900773,70077,70027,8002,6000739,400599,500
       Long-term Assets Other 
55,500
69,500
17,600
9,400
10,400
13,900
10,300
10,700
10,500
19,000
17,100
4,900
3,300
7,900
5,800
2,500
4,500
18,200
15,100
23,400
32,800
60,800
60,80032,80023,40015,10018,2004,5002,5005,8007,9003,3004,90017,10019,00010,50010,70010,30013,90010,4009,40017,60069,50055,500
> Total Liabilities 
1,759,200
1,987,300
1,867,500
1,237,000
1,380,200
1,090,600
1,164,900
1,005,900
1,510,100
1,467,000
1,326,600
260,400
274,900
320,200
344,500
341,500
445,600
562,000
558,500
787,000
1,079,700
1,063,500
1,063,5001,079,700787,000558,500562,000445,600341,500344,500320,200274,900260,4001,326,6001,467,0001,510,1001,005,9001,164,9001,090,6001,380,2001,237,0001,867,5001,987,3001,759,200
   > Total Current Liabilities 
101,200
390,000
1,047,100
520,300
545,100
424,100
386,400
390,200
487,100
506,700
689,900
143,900
218,100
140,900
176,600
199,900
260,000
347,700
233,900
321,000
592,700
588,300
588,300592,700321,000233,900347,700260,000199,900176,600140,900218,100143,900689,900506,700487,100390,200386,400424,100545,100520,3001,047,100390,000101,200
       Short-term Debt 
0
0
390,100
17,100
15,600
8,300
122,600
129,500
158,000
149,300
2,400
100
70,000
59,100
25,700
66,800
116,300
180,100
51,400
84,600
322,000
368,500
368,500322,00084,60051,400180,100116,30066,80025,70059,10070,0001002,400149,300158,000129,500122,6008,30015,60017,100390,10000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
94,500
84,684
0
87,800
116,200
165,400
169,800
42,400
74,700
309,700
356,000
356,000309,70074,70042,400169,800165,400116,20087,800084,68494,50000000000000
       Accounts payable 
0
0
279,700
238,700
192,200
227,600
236,900
223,700
296,700
311,900
60,400
57,700
57,000
69,700
76,200
76,600
87,800
94,300
99,400
128,000
148,300
104,300
104,300148,300128,00099,40094,30087,80076,60076,20069,70057,00057,70060,400311,900296,700223,700236,900227,600192,200238,700279,70000
       Other Current Liabilities 
101,200
390,000
175,400
264,500
132,300
188,200
26,900
37,000
32,400
45,500
60,500
73,400
66,900
59,100
62,100
49,500
52,700
73,300
83,100
108,400
122,400
113,000
113,000122,400108,40083,10073,30052,70049,50062,10059,10066,90073,40060,50045,50032,40037,00026,900188,200132,300264,500175,400390,000101,200
   > Long-term Liabilities 
1,658,000
1,597,300
820,400
716,700
835,100
666,500
778,500
615,700
1,023,000
960,300
636,700
116,500
56,800
179,300
167,900
141,600
185,600
214,300
324,600
466,000
487,000
475,200
475,200487,000466,000324,600214,300185,600141,600167,900179,30056,800116,500636,700960,3001,023,000615,700778,500666,500835,100716,700820,4001,597,3001,658,000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
22,100
25,647
25,100
34,800
24,600
51,500
45,400
40,200
47,400
49,800
0
049,80047,40040,20045,40051,50024,60034,80025,10025,64722,10000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
10,700
33,753
29,400
30,900
31,400
31,600
31,500
31,400
30,700
0
0
0030,70031,40031,50031,60031,40030,90029,40033,75310,70000000000000
> Total Stockholder Equity
739,100
778,100
806,500
946,400
844,900
957,700
941,600
997,800
1,117,200
948,300
858,700
505,200
508,700
487,800
498,500
489,300
520,200
529,100
516,000
554,100
625,700
636,200
636,200625,700554,100516,000529,100520,200489,300498,500487,800508,700505,200858,700948,3001,117,200997,800941,600957,700844,900946,400806,500778,100739,100
   Common Stock
0
0
21,300
19,600
18,200
17,300
0
0
17,200
0
18,200
18,700
16,100
15,600
15,000
14,800
14,800
14,800
14,800
14,800
14,800
14,800
14,80014,80014,80014,80014,80014,80014,80015,00015,60016,10018,70018,200017,2000017,30018,20019,60021,30000
   Retained Earnings Total Equity0000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
68,000
86,600
64,300
71,000
92,100
42,400
53,900
61,900
25,600
25,60061,90053,90042,40092,10071,00064,30086,60068,0000000000000000
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
739,100
778,100
103,400
7,400
14,300
77,300
941,600
42,100
101,900
948,300
123,400
86,400
121,800
58,700
55,800
55,200
55,200
55,200
55,200
55,200
55,200
55,200
55,20055,20055,20055,20055,20055,20055,20055,80058,700121,80086,400123,400948,300101,90042,100941,60077,30014,3007,400103,400778,100739,100



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

Currency in EUR. All numbers in thousands.